Journal rankings · indicator year 2001
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2001
Immunology and Microbiology journal rankings 2001
81 ranked journals · Field in Life Sciences
Immunology and Microbiology has 81 ranked journals in 2001. The median OJR rose 0.08 on 2000 to 0.78, below the world average of 1.00; Q1 starts at OJR 1.17. The top three are Immunity, The Journal of Experimental Medicine, and Nature Immunology.
Ranks and citation indicators: 2001. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1998–2000, the window the 2001 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Immunology and Microbiology (5)
Up to Life Sciences81 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2000. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1998–2000, the window the 2001 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1998–2000 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2001. | Compare |
|---|---|---|---|---|---|---|---|
1ImmunityCell Press · United States | 6.56Q1 | 19.10 1.91 down from 2000 | 466 | 94% | $10,400 | ||
2The Journal of Experimental MedicineRockefeller University Press · United States | 5.21Q1 | 15.06 0.11 up from 2000 | 1,280 | 98% | — | ||
3Nature ImmunologyNature Portfolio · United States | 4.45Q1 | 10.54no 2000 value | 117 | 11% | $12,690 | — | |
4Annual Review of ImmunologyAnnual Reviews · United States | 3.78Q1 | 48.65 3.88 down from 2000 | 84 | 4% | — | ||
5Immunology TodayElsevier BV · United Kingdom | 2.93Q1 | 7.76 0.87 down from 2000 | 513 | — | — | ||
6Critical Reviews in ImmunologyBegell House · United States | 2.38Q1 | 6.21 0.51 down from 2000 | 77 | 0% | — | ||
7Seminars in ImmunologyElsevier BV · United States | 2.23Q1 | 5.11 1.07 down from 2000 | 156 | 4% | $4,370 | ||
8The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.17Q1 | 7.15 0.42 up from 2000 | 5,241 | 49% | $3,500 | ||
9Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.00Q1 | 5.51 1.08 up from 2000 | 1,306 | 42% | $4,900 | ||
10Infection and ImmunityOAAmerican Society for Microbiology · United States | 1.83Q1 | 4.01 0.33 down from 2000 | 3,034 | 98% | — | ||
11International Journal for ParasitologyElsevier BV · Australia | 1.60Q1 | 2.59 0.22 up from 2000 | 589 | 6% | $2,880 | ||
12Journal of Leukocyte BiologyOxford University Press · United States | 1.53Q1 | 4.49 0.15 up from 2000 | 710 | 10% | $3,800 | ||
13International Reviews of ImmunologyTaylor & Francis · United States | 1.47Q1 | 2.18 2.42 down from 2000 | 100 | 0% | — | ||
14European Journal of ImmunologyWiley · Germany | 1.35Q1 | 3.93 0.09 down from 2000 | 1,728 | 55% | $4,550 | ||
15International ImmunologyOxford University Press · United Kingdom | 1.31Q1 | 3.54 0.39 up from 2000 | 608 | 38% | $3,530 | ||
16Parasite ImmunologyWiley · United Kingdom | 1.30Q1 | 2.24 0.47 up from 2000 | 220 | 10% | $4,220 | ||
17Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.29Q1 | 3.29 0.44 up from 2000 | 181 | 0% | $4,990 | ||
18Molecular and Biochemical ParasitologyElsevier BV · Netherlands | 1.29Q1 | 2.48 0.19 down from 2000 | 614 | 5% | $3,460 | ||
19Journal of AutoimmunityElsevier BV · United Kingdom | 1.25Q1 | 2.82 0.69 up from 2000 | 251 | 2% | $5,420 | ||
20Sexually Transmitted DiseasesLippincott Williams & Wilkins · United States | 1.19Q1 | 2.23 0.15 up from 2000 | 349 | 2% | — | ||
21Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.17Q1 | 2.84 0.25 up from 2000 | 957 | 96% | $3,816 | ||
22Journal of NeuroVirologySpringer Science+Business Media · United States | 1.16Q2 | 3.39 0.03 up from 2000 | 194 | 5% | $4,790 | ||
23Sexually Transmitted InfectionsBMJ · United Kingdom | 1.10Q2 | 1.91 0.13 down from 2000 | 339 | 100% | — | ||
24Genes and ImmunitySpringer Nature · United States | 1.09Q2 | 2.91 0.16 up from 2000 | 57 | 4% | $3,190 | ||
25Clinical ImmunologyElsevier BV · Netherlands | 1.06Q2 | 2.72 0.55 up from 2000 | 295 | 2% | $4,400 | ||
26Experimental and Applied AcarologySpringer Science+Business Media | 1.04Q2 | 1.19 0.07 up from 2000 | 205 | 1% | $2,390 | ||
27Current Opinion in ImmunologyElsevier BV · United Kingdom | 1.03Q2 | 11.53 2.42 up from 2000 | 381 | 1% | $4,410 | ||
28Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 0.99Q2 | 1.62 0.56 down from 2000 | 126 | 10% | — | ||
29Immunologic ResearchSpringer Science+Business Media · United States | 0.99Q2 | 3.05 0.71 up from 2000 | 154 | 6% | $2,890 | ||
30ImmunologyWiley · United Kingdom | 0.94Q2 | 2.70 0.46 up from 2000 | 748 | 31% | $5,330 | ||
31Experimental ParasitologyElsevier BV · United States | 0.93Q2 | 1.50 0.15 down from 2000 | 332 | 0% | $3,470 | ||
32Journal of Immunological MethodsElsevier BV · Netherlands | 0.92Q2 | 2.24 0.24 up from 2000 | 639 | 1% | $2,970 | ||
33Immunology and Cell BiologyWiley · Australia | 0.91Q2 | 2.43 0.24 up from 2000 | 252 | 10% | $3,750 | ||
34ImmunopharmacologyElsevier BV · Netherlands | 0.89Q2 | 2.09 0.70 up from 2000 | 330 | — | — | ||
35CytokineElsevier BV · United Kingdom | 0.89Q2 | 2.05 0.36 down from 2000 | 446 | 3% | $3,220 | ||
36Bulletin of the European Association of Fish PathologistsPublisher not listed | 0.83Q2 | 1.10no change | 59 | 0% | — | ||
37Journal of Wildlife DiseasesWildlife Disease Association · United States | 0.82Q2 | 1.18 0.24 up from 2000 | 334 | 79% | — | ||
38Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.81Q2 | 2.33 0.26 up from 2000 | 433 | 1% | — | ||
39Cellular ImmunologyElsevier BV · Netherlands | 0.79Q2 | 2.37 0.52 up from 2000 | 473 | 1% | $3,550 | ||
40Toxicologic PathologySAGE Publishing · United States | 0.78Q2 | 1.61 0.60 down from 2000 | 324 | 28% | $4,150 | ||
41Human ImmunologyElsevier BV · United States | 0.78Q2 | 2.19 0.34 up from 2000 | 439 | 3% | $3,600 | ||
42Journal of Reproductive ImmunologyElsevier BV · Netherlands | 0.73Q3 | 1.91 0.11 down from 2000 | 154 | 0% | $3,690 | ||
43Tissue AntigensWiley · United Kingdom | 0.73Q3 | 3.04 0.62 up from 2000 | 532 | 12% | — | ||
44ImmunogeneticsSpringer Science+Business Media · Germany | 0.72Q3 | 2.10 0.01 up from 2000 | 449 | 2% | $2,890 | ||
45Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.72Q3 | 2.81 1.06 up from 2000 | 198 | 10% | $3,340 | ||
46Immunological ReviewsWiley · United States | 0.68Q3 | 7.08 0.59 up from 2000 | 356 | 6% | $5,000 | ||
47Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.67Q3 | 1.63 0.22 down from 2000 | 527 | 55% | $4,480 | ||
48ImmunobiologyOAElsevier BV · Germany | 0.67Q3 | 1.06 0.63 down from 2000 | 230 | 2% | $2,840 | ||
49American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.66Q3 | 1.76 0.01 down from 2000 | 280 | 6% | $4,460 | ||
50Immunology LettersElsevier BV · Netherlands | 0.64Q3 | 1.90 0.30 up from 2000 | 495 | 3% | $3,290 |
Subfields of Immunology and Microbiology, compared.
Journals
Citations made in 2001. Corpus-wide, 67.0% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Immunology and Microbiology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1998–2000, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2001. Publication window: 1998–2000. How these summaries are calculated
- Ranked journals
- 81
- Window papers (baseline)
- 61,729 Change unavailable from indicator year 1998
- Median OJR
- 0.78 Change unavailable from indicator year 1998
- Rising journals (2025)
- 12Comparison-group list (12)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1998–2000 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 77 | 81 | 84 | 87 | 84 | 88 | 92 | 96 | 96 | 99 | 100 | 109 | 113 | 118 | 117 | 124 | 126 | 135 | 135 | 131 | 134 | 128 | 131 | 132 | 133 | 130 | |
| Window papers (baseline) | 57,420 | 61,729 | 64,988 | 68,564 | 70,081 | 74,504 | 79,076 | 85,172 | 89,884 | 96,132 | 103,748 | 109,236 | 113,003 | 114,572 | 119,036 | 122,584 | 124,030 | 123,505 | 122,958 | 123,895 | 126,939 | 132,755 | 139,280 | 143,532 | 145,253 | 146,708 | |
| Median OJR | 0.70 | 0.78 | 0.80 | 0.76 | 0.79 | 0.837 | 0.88 | 0.945 | 0.98 | 1.15 | 1.11 | 1.089 | 1.07 | 1.04 | 1.052 | 1.053 | 1.092 | 0.99 | 0.954 | 0.948 | 0.89 | 0.847 | 0.841 | 0.854 | 0.87 | 0.853 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 116 journals |
| Retracted papers per 1,000 | Pooled rate: 1.118 per 1,000 | 102 journals |
| Output growth | Median: -14.5% | 121 journals |
| Open access share | Median: 82.5% | 130 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,340 | 99 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 25.3% | 128 journals |
| Review share | Median: 1.1% | 130 journals |
| Articles-only OJR | Median: 0.85 | 125 journals |
| Uncited share | Median: 25.6% | 130 journals |
| Citation concentration | Median: 42.4% | 130 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.